Novel pleuromutilins for the oral and intravenous treatment of community and hospital-associated methicillin-resistant Staphyococcus aureus (MRSA) infections (360G-Wellcome-087691_Z_08_A)
Funding Organization
£1,085,180
Recipient Organization
Do not Publish
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 1085180 |
Applicant Surname | Payne |
Approval Committee | Seeding Drug Discovery Committee |
Award Date | 2010-03-29T00:00:00+00:00 |
Financial Year | 2009/10 |
Grant Programme: Title | Seeding Drug Discovery Award |
Internal ID | 087691/Z/08/A |
Lead Applicant | Dr David Payne |
Partnership Value | 1085180 |
Planned Dates: End Date | 2012-03-31T00:00:00+00:00 |
Planned Dates: Start Date | 2009-02-01T00:00:00+00:00 |
Recipient Org: Country | United States |
Region | International |